Oshi Health
Founded 2018 Β· 203 employees on LinkedIn Β· 8 known investors
Oshi provides virtual gastrointestinal care delivered by gastroenterologists, dietitians, and gut-brain specialists to patients seeking treatment for GI conditions. The platform combines evidence-based dietary intervention and mental health support to help patients manage digestive health symptoms.
Also known as Oshi
Founders & leadership
Investors Β· 8
Also in the syndicate Β· 1
Company profile
researched Aug 2026Oshi Health operates a virtual gastrointestinal (GI) "center of excellence" that diagnoses and treats digestive symptoms and conditions through remote visits. Patients are assigned a multidisciplinary care team consisting of advanced practice providers, registered dietitians, behavioral health/gut-brain specialists and care coordinators, overseen by board-certified gastroenterologists. The model combines medical evaluation and prescribing with dietary intervention and gut-brain behavioral approaches such as cognitive behavioral therapy and gut-directed hypnotherapy, and includes unlimited virtual visits, in-app messaging support and a 24/7 urgent support line, with next-day, evening and weekend appointment availability.
Conditions treated include acid reflux and GERD, irritable bowel syndrome, bloating, abdominal pain, Crohn's disease, ulcerative colitis, small intestinal bacterial overgrowth and undiagnosed GI symptoms. The company states it works to limit unnecessary or repeat testing and takes a concierge approach to arranging in-network testing when needed. Care is delivered through the Oshi app, and the company also publishes consumer-facing gut health content and educational resources.
Oshi Health is available in all 50 states and describes itself as an in-network benefit for more than 40 million people. It works with employers, health plans, health systems and community GI practices, and maintains a roster of in-person GI practice partners. Leadership includes CEO Sam Holliday, Chief Medical Officer Dr. Sameer Berry, President and COO Danny Krifcher, CTO Martin Anderson, Chief Product Officer Paula Buzzard, Chief Growth Officer Mike Goodman and Chief People Officer Brittany Flanagan, supported by a medical advisory group of gastroenterology academics.
Founding story
CEO Sam Holliday's motivation was personal: in 2017 his mother was diagnosed with irritable bowel syndrome and directed toward the low FODMAP diet, which she had to navigate largely on her own. A stressful life event triggered a flare that sent her to the emergency room and hospital. Examining why she had not received adequate care led Holliday to build a service that would democratize access to proven dietary and gut-brain psychology care with the goal of symptom control.
Business model
Oshi Health delivers virtual GI care as a covered, in-network clinical service rather than a cash-pay wellness product. It contracts with health plans, employers, health systems and community GI practices, positioning its care as value-based: the company cites a payer-conducted analysis showing total medical cost savings of $10,292 per patient over six months from reduced testing, procedures, ER visits and medication use. Employer partners cited include Dayforce, Koch Inc., Mariner, Nielsen and TE Connectivity.
Care is billed as an in-network benefit through major insurance plans, with employer and health plan partnerships underpinning coverage; the company has stated it projects profitability in 2027.
Traction
Oshi reports availability in all 50 states, in-network status covering more than 40 million Americans, 47,000+ people served, and 98% patient satisfaction. It has partnered with employers including Dayforce, Koch Inc., Mariner, Nielsen and TE Connectivity, with dozens more employer programs slated to launch, and has a growing set of in-person GI practice partners. Total disclosed funding stands at $119.5 million.
Latest developments
In October 2024 Oshi announced a $60 million Series C led by Oak HC/FT with participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures, bringing total funding to $119.5 million. The company said the capital would fund additional provider group partnerships, broader payer coverage, new employer programs and expansion into Medicare populations beginning in 2025, with stated ambitions to enter Medicare Advantage and the Department of Veterans Affairs system. Holliday said the round was initiated when an investor approached the company unprompted, and that the financing should carry Oshi to projected profitability in 2027. The company's newsroom lists subsequent publications, including a peer-reviewed study of more than 11,000 patients, a prospective study in the American Journal of Gastroenterology on outcomes and healthcare costs, and a survey on digestive side effects among GLP-1 users.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company positions itself as the category leader in virtual digestive care, differentiating from traditional fee-for-service GI practices that focus on testing and procedures. An investor at Oak HC/FT noted that brick-and-mortar GI practices lack the bandwidth to deliver the level of longitudinal, multidisciplinary support Oshi provides.
Oshi integrates medical, dietary and gut-brain behavioral care in one team-based model and has invested in clinical evidence: a two-year study conducted with a national health plan reported 92% of patients experiencing symptom improvement, 88% of undiagnosed patients receiving a clear diagnosis within three months, 98% patient satisfaction, and $10,292 in medical cost savings per patient over six months. Management has said this cost-savings proof was central to obtaining health plan coverage.
Technology
Care coordination, scheduling, messaging and administrative workflows are handled through the Oshi app, which supports virtual visits with the multidisciplinary care team and access to a library of gut health resources.
Go-to-market
Distribution runs through payer contracts that make Oshi an in-network benefit, employer benefit programs that promote the service to employees and their families, and referral partnerships with local gastroenterologists, primary care providers and community GI practices. The consumer website supports direct sign-up, insurance eligibility checks and rapid appointment booking, and the company markets via educational gut-health content and a newsletter.
Adults with acute or chronic digestive symptoms and conditions, including undiagnosed patients, reached primarily through their employers and health plans; buyers are health plans, employers, health systems and GI practices.
Geography
United States nationwide, available in all 50 states; the funding announcement was issued from New York. The team operates remote-first.
History
The company traces its origins to 2017, when CEO Sam Holliday's mother was diagnosed with IBS and subsequently hospitalized after a stress-triggered flare, prompting him to focus on gaps in digestive care. Oshi states it has been operating in virtual GI care since 2019, and its corporate materials describe the service as launched in 2020. In 2022 the company ran a clinical study with a national health plan to demonstrate efficacy and cost savings, which it credits with unlocking payer coverage. A $30 million round backed by CVS Health Ventures and Takeda Digital Ventures preceded a $60 million Series C announced in October 2024 led by Oak HC/FT.
Risks & controversies
The company has posted a warning that scammers are impersonating Oshi Health through fake phone numbers, email addresses and social accounts to make fraudulent employment approaches, and asks recipients to report such communications.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Competitors Β· 2
by search overlapCompanies competing with Oshi Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 7
launches, deals, and filingsCompany published survey findings reporting that digestive side effects cause 41% of GLP-1 users to suffer in silence, self-adjust, or consider quitting.
Company newsroom entry announcing a prospective study validating improved outcomes and reduced healthcare costs through virtual multidisciplinary GI care.
Company newsroom entry announcing publication of a peer-reviewed study of more than 11,000 patients validating virtual multidisciplinary GI care at scale.
Company stated it would expand into Medicare populations beginning in 2025, with stated interest in Medicare Advantage and the Department of Veterans Affairs medical system.
Virtual GI care company announced a $60 million Series C led by Oak HC/FT, the only new investor, with participation from existing backers Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. Proceeds are earmarked for more health plan and provider group contracts, employer programs and expansion into Medicare populations beginning in 2025.
$60M source β
Oshi Health disclosed benefit partnerships with employers including Dayforce, Koch Inc., Mariner, Nielsen and TE Connectivity, with dozens more employer programs launching by year-end.
Oshi conducted a study of its care model with a payer covering a large commercially insured population; results reported 92% symptom improvement, 98% patient satisfaction and $10,292 in total medical cost savings per patient over six months. Data were published at the Institute for Healthcare Improvement.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Oshi Healthoshihealth.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Oshi Health do?
- Oshi Health is a virtual gastrointestinal clinic offering insurance-covered, multidisciplinary GI care across the US.
- Who are Oshi Health's investors?
- Oshi Health's investors include Bessemer Venture Partners, CVS Health Ventures, Flare Capital Partners, Frist Cressey Ventures, Koch Disruptive Technologies, Oak HC/FT, Takeda Ventures.